Clover Health Investments (CLOV) KeyBanc Capital Markets Technology Leadership Forum summary

Business model and technology

• Focuses on Medicare Advantage using a PPO structure, leveraging an AI-powered technology stack since 2018 to support primary care physicians at the point of care.

• Clover Assistant, a cloud-based platform, integrates over 100 data sources to recommend care paths and improve early diagnosis of chronic diseases.

• Demonstrated ability to lower medical cost ratios and improve patient outcomes, with technology now available to other Medicare Advantage plans.

• Majority of members are in New Jersey, with presence in Georgia, Texas, and other states, targeting organic growth and software adoption in these regions.

• Leadership team has deep technology backgrounds, with experience from Google, Yahoo, and Omnicell.

Counterpart Health platform and growth strategy

• Counterpart Health, a new subsidiary, offers the proven technology platform to external payers and at-risk providers, aiming to lower medical cost ratios by 10% over multiple years.

• Revenue model includes per-member-per-month SaaS fees and shared savings, with multi-year contracts and renewal/expansion options.

• Implementation is rapid (one day), with physician training in one hour, and the platform features an intuitive, Apple-like user interface.

• Gross margin profile is below typical SaaS levels but meaningfully above the insurance plan side, with national scalability and a rich pipeline of deals.

• Go-to-market strategy targets both payers and providers, with equal opportunity seen in both segments.

Financial performance and outlook

• Reported 11% organic revenue growth year-over-year, $36 million adjusted EBITDA for Q2, $43 million for the first half, and positive net income.

• Generated $46 million in operating cash flow, with all metrics exceeding internal and consensus expectations.

• Maintains a strong balance sheet with no debt and over $450 million in total cash, including $201 million in unrestricted cash.

• No anticipated need for external funding to support ongoing growth and profitability.

• Technology and innovation roadmap updates are now included in earnings communications.